Back

Loss of microglia reduces NGF signaling and retinal ganglion cell survival

Buccarello, L.; Ribbeni, G.; Ricceri, L.; Livero, O.; Cattaneo, A.; Mariinelli, S.

2026-03-29 neuroscience
10.64898/2026.03.26.714400 bioRxiv
Show abstract

Nerve growth factor (NGF) exerts neuroprotective effects in the retina, and accumulating evidence indicates that microglia represent a key cellular target of NGF/TrkA signaling. However, evidence showing that the NGF/TrkA signaling in microglia is required for downstream neuroprotective actions remains unresolved. Here, we directly addressed this question by pharmacologically depleting microglia and assessing the impact on NGF pathway activity and retinal integrity. Adult C57BL/6J mice were treated with the CSF1R inhibitor PLX5622 for three weeks, resulting in a robust ([~]77%) depletion of retinal microglia. Microglial ablation induced marked structural and cellular alterations, including significant loss of retinal ganglion cells (RGCs) and thinning of retinal layers, in the absence of any other lesion or insult. Residual microglia exhibited layer-specific phenotypic changes, with a phagocytic profile in the ganglion cell layer and a more ramified morphology in the outer plexiform layer. Strikingly, microglial depletion led to a profound decrease of NGF signaling, with a strong reduction in total and phosphorylated TrkA, and decreased p75NTR levels, in retinal extracts. The amount of TrkA expression is strongly correlated with microglial levels, supporting a primary role of microglia in sustaining NGF signaling in the retina. Together, these findings demonstrate that microglia are required for NGF/TrkA signaling and identify these cells as essential mediators of NGF-dependent neuroprotection in the retina.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
Journal of Neuroinflammation
50 papers in training set
Top 0.1%
10.4%
2
Cell Death & Disease
126 papers in training set
Top 0.1%
8.2%
3
eLife
5422 papers in training set
Top 11%
6.8%
4
Cell Reports
1338 papers in training set
Top 10%
4.8%
5
The Journal of Neuroscience
928 papers in training set
Top 3%
3.7%
6
Glia
74 papers in training set
Top 0.1%
3.6%
7
Nature Communications
4913 papers in training set
Top 40%
3.6%
8
eneuro
389 papers in training set
Top 3%
3.6%
9
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 22%
3.2%
10
Experimental Neurology
57 papers in training set
Top 0.3%
3.1%
50% of probability mass above
11
JCI Insight
241 papers in training set
Top 2%
3.1%
12
Aging Cell
144 papers in training set
Top 2%
2.6%
13
Neuron
282 papers in training set
Top 5%
2.1%
14
iScience
1063 papers in training set
Top 12%
1.9%
15
Molecular Therapy
71 papers in training set
Top 1%
1.9%
16
Scientific Reports
3102 papers in training set
Top 56%
1.8%
17
Molecular Neurodegeneration
49 papers in training set
Top 0.5%
1.7%
18
Developmental Cell
168 papers in training set
Top 8%
1.7%
19
PLOS Biology
408 papers in training set
Top 12%
1.3%
20
Neurobiology of Disease
134 papers in training set
Top 3%
1.3%
21
The FASEB Journal
175 papers in training set
Top 2%
1.3%
22
Brain
154 papers in training set
Top 4%
1.1%
23
Science Advances
1098 papers in training set
Top 26%
0.9%
24
Nature Neuroscience
216 papers in training set
Top 5%
0.9%
25
PLOS ONE
4510 papers in training set
Top 64%
0.9%
26
Investigative Opthalmology & Visual Science
37 papers in training set
Top 0.6%
0.8%
27
Acta Neuropathologica Communications
81 papers in training set
Top 1%
0.7%
28
Redox Biology
64 papers in training set
Top 1.0%
0.7%
29
EMBO Molecular Medicine
85 papers in training set
Top 4%
0.7%
30
EMBO reports
136 papers in training set
Top 6%
0.7%